Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Anxa3em1/Cya
Common Name:
Anxa3-KO
Product ID:
S-KO-01050
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Anxa3-KO
Strain ID
KOCMP-11745-Anxa3-B6N-VA
Gene Name
Anxa3
Product ID
S-KO-01050
Gene Alias
Anx3
Background
C57BL/6NCya
NCBI ID
11745
Modification
Conventional knockout
Chromosome
5
Phenotype
MGI:1201378
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Anxa3em1/Cya mice (Catalog S-KO-01050) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000031447
NCBI RefSeq
NM_013470
Target Region
Exon 3~6
Size of Effective Region
~9.4 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Anxa3, or annexin A3, is a member of the annexin family. It is involved in multiple biological processes and associated with various signaling pathways, such as the AKT-GSK3β-β-catenin pathway. It plays important roles in cell function regulation, and its abnormal expression is linked to the development of numerous diseases, making it a potential target for disease treatment [1-10].

In laryngeal squamous cell carcinoma, ANXA3 in tumor-associated macrophages promotes M2-like polarization via the AKT-GSK3β-β-catenin pathway. ANXA3-rich exosomes from these macrophages inhibit ferroptosis in laryngeal cancer cells through an ATF2-CHAC1 axis, which is associated with lymphatic metastasis [1]. In cervical cancer, ANXA3 is highly expressed, and its knockdown inhibits cell cycle progression and increases cisplatin sensitivity. Its expression is positively correlated with YAP1 [2]. ANXA3 may be a novel diagnostic biomarker for sepsis, as its transcription was significantly higher in the peripheral blood of septic mice compared to healthy controls [3]. In colon cancer, ANXA3 expression is upregulated by hypoxia-inducible factor 1-alpha (HIF-1α) and contributes to tumor growth [4]. In ischemic stroke, ANXA3 was identified as a possible pyroptosis-related gene marker, and its silencing alleviated the expression of pyroptosis-related factors [5]. In HCV infection, ANXA3 is an important host factor, and proximity labeling revealed a novel LARP1 function in viral entry [6]. In lung cancer, knocking down ANXA3 inhibits the resistance of lung cancer cells to oxaliplatin [7]. In intracranial aneurysm, ANXA3 silencing can rescue vascular smooth muscle cell function by inhibiting the phosphorylation and activation of the JNK signaling pathway [8]. Epstein-Barr virus upregulates the ANXA3-HIF-1α-VEGF pathway, causing vascular abnormalities in epithelial malignancies, and ANXA3 blockade may be a potential therapy [9]. The 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis by modulating the ERK, PI3K/Akt-HIF, and intrinsic apoptosis pathways [10].

In conclusion, Anxa3 is involved in diverse biological functions, including cell polarization, ferroptosis regulation, cell cycle progression, and apoptosis. Its abnormal expression is associated with multiple diseases such as various cancers, sepsis, and ischemic stroke. Studies on Anxa3, especially through gene-based models like knockdown experiments, help in understanding disease mechanisms and developing potential therapeutic strategies for these diseases.

References:

1. Xu, Licheng, Li, Wenjing, Liu, Danxi, Liu, Ming, Tian, Linli. . ANXA3-Rich Exosomes Derived from Tumor-Associated Macrophages Regulate Ferroptosis and Lymphatic Metastasis of Laryngeal Squamous Cell Carcinoma. In Cancer immunology research, 12, 614-630. doi:10.1158/2326-6066.CIR-23-0595. https://pubmed.ncbi.nlm.nih.gov/38393971/

2. Huang, Jiazhen, Wei, Wei, Kang, Fuli, Lu, Xiaohang, Wang, Ning. 2023. ANXA3, associated with YAP1 regulation, participates in the proliferation and chemoresistance of cervical cancer cells. In Genes & genomics, 45, 1575-1586. doi:10.1007/s13258-023-01461-y. https://pubmed.ncbi.nlm.nih.gov/37843781/

3. Zhang, Jing-Xiang, Xing, Xin-Hao, Lu, Ren-Yi, Zhao, Qing-Jie, Wang, Yan. 2024. ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis. In Heliyon, 10, e38608. doi:10.1016/j.heliyon.2024.e38608. https://pubmed.ncbi.nlm.nih.gov/39430518/

4. Du, Kunli, Ren, Jiahui, Fu, Zhongxue, Zheng, Jianyong, Li, Xing. . ANXA3 is upregulated by hypoxia-inducible factor 1-alpha and promotes colon cancer growth. In Translational cancer research, 9, 7440-7449. doi:10.21037/tcr-20-994. https://pubmed.ncbi.nlm.nih.gov/35117344/

5. Liu, Linquan, Cai, Yahong, Deng, Changqing. 2023. Identification of ANXA3 as a biomarker associated with pyroptosis in ischemic stroke. In European journal of medical research, 28, 596. doi:10.1186/s40001-023-01564-y. https://pubmed.ncbi.nlm.nih.gov/38102696/

6. Bley, Hanna, Krisp, Christoph, Schöbel, Anja, Gerold, Gisa, Herker, Eva. 2024. Proximity labeling of host factor ANXA3 in HCV infection reveals a novel LARP1 function in viral entry. In The Journal of biological chemistry, 300, 107286. doi:10.1016/j.jbc.2024.107286. https://pubmed.ncbi.nlm.nih.gov/38636657/

7. Jin, Y-F, Huang, Y-T, Chen, P-F. . ANXA3 deletion inhibits the resistance of lung cancer cells to oxaliplatin. In European review for medical and pharmacological sciences, 24, 3741-3748. doi:10.26355/eurrev_202004_20838. https://pubmed.ncbi.nlm.nih.gov/32329851/

8. Wang, Yang, Wang, Chun, Yang, Qi, Cheng, Yan-Li. 2019. ANXA3 Silencing Ameliorates Intracranial Aneurysm via Inhibition of the JNK Signaling Pathway. In Molecular therapy. Nucleic acids, 17, 540-550. doi:10.1016/j.omtn.2019.06.005. https://pubmed.ncbi.nlm.nih.gov/31362241/

9. Chen, Yuanyuan, Di, Muping, Tang, Yan, Xiang, Tong, Xia, Jianchuan. 2024. Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway. In Oncogene, 43, 2143-2159. doi:10.1038/s41388-024-03061-w. https://pubmed.ncbi.nlm.nih.gov/38778160/

10. Guo, Chunmei, Li, Nannan, Dong, Chengyong, Liu, Shuqing, Sun, Ming-Zhong. 2020. 33-kDa ANXA3 isoform contributes to hepatocarcinogenesis via modulating ERK, PI3K/Akt-HIF and intrinsic apoptosis pathways. In Journal of advanced research, 30, 85-102. doi:10.1016/j.jare.2020.11.003. https://pubmed.ncbi.nlm.nih.gov/34026289/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest